175
Views
59
CrossRef citations to date
0
Altmetric
Original Article

Green tea polyphenol extract attenuates colon injury induced by experimental colitis

, , , , , , & show all
Pages 1017-1025 | Received 04 Mar 2005, Published online: 07 Jul 2009

References

  • Kitahara T, Suzuki K, Asakura H, Yoshida T, Suematsu M, Watanabe M, Aiso S, Tsuchiya M. Active oxygen species generated monocytes and polymorphnuclear cells in Crohn's disease. Dig Dis Sci 1988;33:951–955.
  • Crama-Bohbouth GE, Arndt JW, Pena AS, Verspaget HW, Tjon A, Tham RT, Weterman IT, Pauwels EK, Lamers CB. Value of indium- 111 granulocyte scintigraphy in the assessment of Crohn's disease of the small intestine: Prospective investigation. Digestion 1988;40: 227–236.
  • Cuzzocrea S, Riley DP, Caputi AP, Salvemini D. Anti-oxidant therapy: A new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury. Pharmacol Rev 2001;53:135–159.
  • Vinson JA. Black and green tea and heart disease: A review. Biofactors 2000;13:127–132.
  • Middleton Jr, E, Kandaswami C, Theoharides TC. The effects of plant flavonoids on mammalian cells: Implications for inflammation, heart disease, and cancer. Pharmacol Rev 2000;52:673–751.
  • Miura Y, Chiba T, Miura S, Tomita II, Umegaki K, Ikeda M, Tomita T. Green tea polyphenols (flavan 3-ols) prevent oxidative modification of low densitity lipoproteins: An ex vivo study in humans. J Nutr Biochem 2000;11: 216–222.
  • Dona M, Dell'aica I, Calabrese F, Benelli R, Morini M, Albini A, Garbisa S. Neutrophil restrain by green tea: Inhibition of inflammation, associated angiogenesis, and pulmonary fibro-sis. J Immunol 2003;170:4335–4341.
  • Levites Y, Amit T, Youdim MB, Mandel S. Involvement of green protein kinase C activation and cell survival/cell cycle genes in green tea polyphenol (— )-epigallocatechin 3-gallate neuroprotective action. J Biol Chem 2002;277:30574–30580.
  • Kim HS, Kim MH, Jeong M, Hwang YS, Lim SH, Shin BA, Ahn BW, Jung YD. EGCG blocks tumor promotor-induced MMP-9 expression via suppression of MAPK and AP-1 activation in human gastric AGS cells. Anticancer Res 2004;24:747–753.
  • Menegazzi M, Tedeschi E, Dussin D, Carcereri A, Cavalieri E, Mariotto S, Suzuki H. Anti interferon-y action of epigallo-catechin-3-galllate by specific inhibition of STAT-1 activation. FASEB J 2001;15(7):1309–1311.
  • Varilek GW, Yang F, Lee EY, deVilliers WJ, Zhong J, Oz HS, Westberry KF, McClain CJ. Green tea polyphenol extract attenuates inflammation in interleukin-2-deficient mice, a model of autoimmunity. J Nutr 2001;131:2034-2039. Townsend PA, Scarabelli TM, Pasini E, Gitti G, Menegazzi
  • M, Suzuki H, Knight RA, Latchman DS, Stephanou A. Epigallocatechin-3-gallate inhibits STAT-1 activation and protects cardiac myocytes from ischemia/reperfusion-induced ap optos is. FASEB J 2004;18: 1621–1623.
  • Wallace JL, Keenan CM, Gale D. Exacerbation of experimen-tal colitis by non-steroidal ant inflammatory drugs is not related to elevate leukotriene B4 synthesis. Gastroenterology 1992;102: 18–27.
  • Miller MJ, Thompson JH, Zhang XJ, Sadowska-Krowicka H, Kakkis JL, Munshi UK, Sandoval M, Rossi JL, Eloby-Childress S, Beckman JS, et al. Role of inducible nitric oxide synthase expression and peroxynitrite formation in guinea pig ileitis. Gastroenterology 1995;109:1475–1483 .
  • Mullane KM, Kraemer R, Smith B. Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J Pharmacol Method 1985; 14:157–167.
  • Diaz-Granados N, Howe K, Lu J, McKay DM. Dextran sulfate sodium-induced colonic histopathology, but not altered epithelial ion transport, is reduced by inhibition of phospho-diesterase activity. Am J Pathol 2000;156:2169–2177.
  • Cuzzocrea S, Mazzon E, Dugo L, Caputi AP, Riley DP, Salvemini D. Protective effects of M40403, a superoxide dismutase mimetic, in a rodent model of colitis. Eur J Pharmacol 2001;432:79–89.
  • Eiserich JP, Hristova M, Cross CE, Jones AD, Freeman BA, Halliwel B, Van der Vliet A. Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature 1998;391:393–397.
  • Singer II, Kawka DW, Scott S, Weidner JR, Mumford RA, Riehl TE, Stenson WF. Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in inflamma-tory bowel disease. Gastroenterology 1996;111:871–885.
  • Rachmilewitz D, Stamler JS, Karmeli F, Mullins ME, Singel DJ, Loscalzo J, Xavier RJ, Podolsky DK. Peroxynitrite-induced rat colitis-a new model of colonic inflammation. Gastroenterology 1993;105:1681–1688.
  • Higdon JV, Frei B. Tea catechins and polyphenols: Health effects, metabolism, and antioxidant functions. Grit Rev Food Sci Nutr 2003;43:89–143.
  • Carty E, De Brabander M, Feakins RM, Rampton DS. Measurement of in vivo rectal mucosal cytokine and eicosanoid production in ulcerative colitis using filter paper. Gut 2000;46:487–492.
  • Cuzzocrea S. Emerging biotherapies for inflammatory bowel disease. Expert Opin Emerg Drugs 2003;8:339–347.
  • Shiratora Y, Aoki S, Takada H, Kiriyama H, Ohto K, Hai K, Teraoka H, Matano S, Matsumoto K, Kamii K. Oxygen-derived free radical generating capacity of polymorphonuclear cells in patients with ulcerative colitis. Digestion 1989;44:163–171.
  • Salvemini D, Riley DP, Lennon PJ, Wang ZQ, Currie MG, Macarthur H, Misko TP. Protective effects of a superoxide dismutase mimetic and peroxynitrite decomyeloperoxidasesi-tion catalysts in endotoxin-induced intestinal damage. Br J Pharmacol 1999;127:685–692.
  • Clark JE, Foresti R, Sarathchandra P, Kaur H, Green CJ, Motterlini R. Heme-oxygenase- 1 -derived bilirubin amelio-rates postischcaemic myocardial dysfunction. Am J Physiol 2000;278:H643—H651.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.